Resources

A physician at the FDA, provided new data that shows there is a serious problem regarding patient safety in insulin pump use. She reported data on 1594 injuries and 13 deaths in children and adolescents collected over 10 years. 82% of the cases resulted in hospitalization.

Inflammatory markers are independent predictors of congestive heart failure (CHF) and likely reflect the link between obesity and CHF, a new study suggests. “The implication may be that greater control of obesity may reduce the risk of heart failure and down the road, maybe targeting inflammatory markers may reduce the …

Researchers have identified new genetic variants that influence the risk of obesity, and insulin resistance, a precursor to diabetes, according to findings from two studies published online this week.

A team at DukeUniversityMedicalCenter was able to tone down appetite and promote weight loss, while improving the body’s ability to handle blood sugar levels by blocking a brain enzyme, CaMKK2.

The pharmaceutical industry is pressing the Food and Drug Administration for greater freedom to give doctors copies of scientific studies about experimental uses of their drugs. And the FDA is considering lighter restrictions. Does this mean we will get label disclaimers like nutritional products? Will manufacturers have put on the …

Does adding a little simple resistance to your exercise actually make a difference? Have your patients try this weeks Upper-body resistance training exercises: Double-arm row and lat pull-down shared with us by Dr. Sheri Colberg, Ph.D., FACSM and see the difference yourself.

Canadian, French and British researchers have identified a DNA sequence that controls the variability of blood glucose levels in people. This is a potentially significant discovery because, 80 per cent of the risk of cardiovascular disease is related to a blood glucose level just above the average and high blood glucose …

Yes, you can stop diabetes before it begins, but you won’t receive the care you need if you don’t even know you have the problem. Screening is now recommended for everyone beginning at 45 years of age.

New analysis of a landmark study data Identifies major predictors of new-onset diabetes (NOD) among hypertensives. Of 19,257 randomized patients in the study, 14,120 were considered “at risk” of developing diabetes at baseline, and 1,366 (9.7%) subsequently developed NOD during follow-up (median duration, 5.5 years).

Aspirin-like compounds (salicylates) can claim another health benefit: increasing the amount of insulin produced by otherwise healthy obese people. Obesity is associated with insulin resistance, the first step toward type 2 diabetes.